OrthoPediatrics Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by OrthoPediatrics Corp. on March 6, 2019. The filing serves to announce the Company's earnings results for the quarter and full year ended December 31, 2018. The Company is incorporated in Delaware and identifies as an emerging growth company.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These financial metrics are contained within the press release and unaudited condensed consolidated financial statements furnished as Exhibit 99.1, which are incorporated by reference but not detailed in the body of this 8-K.
Material Changes
No specific material changes versus prior periods are quantified in this document. The filing indicates that the Company has issued a press release containing the comparative financial data and other disclosures.
Guidance, Outlook, and Risks
This document does not contain specific guidance, outlook, management commentary, or risk factors. It explicitly states that the information is furnished pursuant to Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 6, 2019) for actual revenue, net income, and cash flow figures.
- Examine the unaudited condensed consolidated financial statements in Exhibit 99.1 for year-over-year comparisons.
- Verify the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm the specific details of the earnings announcement and any forward-looking statements made in the referenced press release.